Tag: medicines
News and press releases: European Medicines Agency website unavailable intermittently Saturday 6 October
The European Medicines Agency’s website, ema.europa.eu, will be unavailable intermittently between 8.00am and 6.00pm on Saturday 6 October 2012, due to a test of the Agency’s disaster recovery plan. Patient safety, news and press releases: human and vet
News and press releases: Speakers confirmed for European Medicines Agency workshop on clinical-trial data and transparency
The European Medicines Agency has confirmed the panel of speakers at its workshop on clinical-trial data and transparency on 22 November 2012. Patient safety, news and press releases: human and vet
Ethical considerations for paediatric trials – how can ethics committees in the European Member States and the Paediatric Committee at the European Medicines Agency work together?, European Medicines Agency, London, UK, From: 29-Nov-2011, To: 30-Nov-2011
This two-day workshop is on ethical aspects of the design and conduct of clinical trials with the paediatric population for medicine development. It is aimed at ethics committee members assessing paediatric trials, European regulators including methodology experts and participants with a scientific background or paediatric experience from ethics committees, paediatric research networks, pharmaceutical companies or [...]
Workshop on development of new antibacterial medicines, European Medicines Agency, London, UK, From: 25-Oct-2012, To: 26-Oct-2012
This workshop’s aim is to discuss aspects of the development of antibacterial medicinal products, including those targeting multiple-drug-resistant pathogens and with narrow-action spectra and discussion on specific indications. Participation is invitation-based only. Webinar access to a limited number of registered users is possible: register by 24 October 12:00 UK time. Meetings and events
The annual European Medicines Agency review of the Year and outlook for 2013, De Vere Venues, Canary Wharf, London, UK, From: 29-Nov-2012, To: 30-Nov-2012
This is the seventh annual review of the ativities of the European Medicines Agency, which looks towards the next year – a firm favorite with many European regulatory-affairs personnel as the key year end event to reflect on the year gone by and to plan for the upcoming year. Meetings and events
Human medicines European Public Assessment Report (EPAR): Riprazo HCT , aliskiren / hydrochlorothiazide, Revision: 0, Withdrawn
Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products
